A ctDNA dynamic detection model was preliminarily established for the treatment of muscular layer invasive bladder cancer and its recurrence and metastasis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036255

Enrollment

Unknown

Registered

2020-08-22

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder tumor

Interventions

Gold Standard:Clinical outcome

Index test:ctDNA&#32

dynamic&#32

detection&#32

model&#32

Eligibility

Sex/Gender

All

Age

20 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18-70 years, male or female; 2) Patients clinically diagnosed with radical resectable MIBC (T2-T4A);; 3) Cancer of other tissues or organs has not been diagnosed; 4) The expected survival time is more than 6 months; 5) Subjects voluntarily participate in this study and sign informed consent, with good compliance and follow-up.

Exclusion criteria

Exclusion criteria: 1) Simultaneous diagnosis of cancer in other tissues or organs; 2) Received radiotherapy, chemotherapy, surgery or molecular targeted therapy.

Design outcomes

Primary

Measure	Time frame
ctDNA;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactWang Xiang

Shanghai General Hospital

drseanwang@163.com+86 13817678451

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026